Trial
NCT02462421
Pharmacogenetics of SGLT2 Inhibitors
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Maryland, Baltimore
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Condition
Diabetes Mellitus
Intervention
Canagliflozin
Why stopped
Did not meet recruitment targets.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-02